Review

The Role of Regulatory T Cell Defects in Type I Diabetes and the Potential of these Cells for Therapy

David Thomas, Paola Zaccone, Anne Cooke

Keywords: type 1 diabetes, T cell, Treg cell, Foxp3, dendritic cells

Abstract

Type I diabetes is increasing in incidence in developed countries [1]. Diabetes arises from a breakdown of tolerance to islet antigens, resulting in T cell-driven destruction of the islet cells and concomitant hyperglycemia. In this review, we explore whether this loss of tolerance results in part from a defect in the action of regulatory T cells. We draw on both human data and that obtained from NOD mice, the murine model of autoimmune diabetes. Although insulin-based therapies have been highly successful in treating diabetes, the complications of long-term hyperglycemia are still major causes of morbidity and mortality. Accordingly, we also discuss whether treatment with regulatory T cells is a viable method for restoring long-term tolerance to self-antigens in recently diagnosed or pre-diabetic individuals. Regulatory T cell therapy offers many potential advantages, including a specific and lasting dampening of inflammation. However, some significant hurdles would have to be overcome before it could become an established treatment.

Fulltext: HTML , PDF (455KB)

This article has been cited by other articles:

	New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes Jimeno R, Gomariz RP, Gutierrez-Canas I, Martinez C, Juarranz Y, Leceta J Immunol Cell Biol 2010. 88(7):734-745
	Pronounced phenotype in activated regulatory T cells during a chronic helminth infection Layland LE, Mages J, Loddenkemper C, Hoerauf A, Wagner H, Lang R, da Costa CU J Immunol 2010. 184(2):713-724
	microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J, Michalek J Cell Immunol 2010. 260(2):70-74
	AAV8-mediated Gene Transfer of Interleukin-4 to Endogenous beta-Cells Prevents the Onset of Diabetes in NOD Mice Rehman KK, Trucco M, Wang Z, Xiao X, Robbins PD Mol Ther 2008. 16(8):1409-1416
	N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells Mor A, Keren G, Kloog Y, George J Eur J Immunol 2008. 38(6):1493-1502
	Interleukin 22 Receptor 1 Expression in Pancreas Islets Shioya M, Andoh A, Kakinoki S, Nishida A, Fujiyama Y Pancreas 2008. 36(2):197-199
	Development of Live Cell Chips to Monitor Cell Differentiation Processes Maercker C, Rogge T, Mathis H, Ridinger H, Bieback K Eng Life Sci 2008. 8(1):33-39
	Toward cell-based therapy of type I diabetes Kabelitz D, Geissler EK, Soria B, Schroeder IS, Fändrich F, Chatenoud L Trends Immunol 2008. 29(2):68-74
	Increased Regulatory and Decreased CD8+ Cytotoxic T Cells in the Blood of Patients with Idiopathic Pulmonary Arterial Hypertension Ulrich S, Nicolls MR, Taraseviciene L, Speich R, Voelkel N Respiration 2007. 75(3):272-280
	Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus Michalek J, Vrabelova Z, Hrotekova Z, Kyr M, Pejchlova M, Kolouskova S, Faresjo M, Stechova K Scand J Immunol 2006. 64(5):531-535